The development in recent years of sensitive assays specific for albumin has facilitated extensive investigation of the pathophysiology and clinical significance of microalbuminuria. It is now clear that the appearance of microalbuminuria represents a crucial event in the natural histories of diabetes mellitus and essential hypertension. It reflects the presence of generalized vascular damage and is strongly predictive of subsequent renal failure, cardiovascular morbidity, and death. Therapeutic interventions, including strict diabetic and blood-pressure control, can reduce microalbuminuria and improve the overall prognosis. The detection and treatment of microalbuminuria in these high-risk groups should now form an integral part of their management. Large-scale screening programmes are also recommended for insulin-dependent diabetics.
VibertiGCHillRDJarrettRJMicroalbuminuria as a predictor of clinical nephropathy. Lancet1982; 1: 143–1432.
2.
WinocourPHMicroalbuminuria. Br Med J1992; 304: 1196–1197.
3.
RoweDJFDawnayAWattsGFMicroalbuminuria in diabetes mellitus: review and recommendations for the measurement of albumin in urine, Ann Clin Biochem1990; 27: 297–312.
4.
MogensenCEChristensenCKPredicting diabetic nephropathy in insulin-dependent diabetics. N Engl J Med1984; 311: 89–93.
5.
ParvingHHOxenbollBSvendsenPAEarly detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh)1982; 100: 550–555.
6.
MathiesenEROxenbollBJohansenKInsipient nephropathy in Type I diabetes. Diabetologia1984; 26: 406–410.
MarshallSMScreening for microalbuminuria: which measurement?Diabetic Med1991; 8: 706–711.
9.
VibertiGCKeenJThe patterns of proteinuria in diabetes mellitus. Diabetes1984; 33: 686–692.
10.
MogensenCEChaihatiAChristensenCKMicroalbuminuria: an early marker of renal involvement in diabetes. Uraemia Invest1985; 9: 85–92.
11.
VibertiGCWisemanMJThe kidney in diabetes: significance of the early abnormalities. Clin Endocr Metab1986; 15 (4): 753–783.
12.
LjungmanSMicroalbuminuria in essential hypertension. Am J Hypertens1990; 3: 956–960.
13.
RoweDJFBaggaHBettsPBNormal variations in albumin excretion and albumin to creatinine ratios in overnight and daytime urine collections in non-diabetic children. Br Med J1985; 291: 693–694.
14.
BrennerBMHostetterTHHumesHDMolecular basis of proteinuria of glomerular origin. N Engl J Med1978; 298: 826–833.
15.
MyersBDWinetzJAChuiFMechanisms of proteinuria in diabetes mellitus: a study of glomerular barrier function. Kidney Int1982; 21: 633–641.
16.
MogensenCESollingKStudies on renal tubular protein reabsorption, partial and near complete inhibition by certain amino acids. Scand J Clin Lab Invest1977; 37: 477–486.
17.
DennisVWRobinsonRRProteinuria. In: The Kidney: Physiology and Pathophysiology (SeldinDWGiebischG eds). New York, Raven Press, 1985; pp. 1805 –1816.
18.
WestJNGoslingPDimmittSBNon-diabetic microalbuminuria in clinical practice and its relationship to posture, exercise and blood pressure. Clin Sci1991; 81: 373–377.
19.
WisemanMJHuntREGoodwinADietary composition and renal function in healthy subjects. Nephron1987; 46 (1): 37–42.
20.
Feldt-RasmussenBMathiesenERVariability of urinary albumin excretion in insipient diabetic nephropathy. Diab Nephropathy1984; 3: 101–104.
21.
CohenDLCloseCFVibertiGCThe variability of overnight urinary albumin excretion in normal and insulin-dependent diabetic subjects. Diabet Med1987; 4: 437–440.
22.
PedersenEBMogensenCELarsenJSEffects of exercise on urinary excretion of albumin and β-microglobulin in young patients with mild essential hypertension without treatment and during longterm propranolol treatment. Scand J Clin Lab Invest1981; 41: 493–498.
23.
JamesMAFotherbyMDPotterJFMicroalbuminuria in elderly hypertensives, variability and relation to clinic and ambulatory blood pressure. J Hypertens1992; 10 (11): 1431 (abstract).
24.
HoweyJEABrowningMCKFraserCGBiologic variation of urinary albumin: consequences for analysis, specimen collection, interpretation of results, and screening programmes. Am J Kidney Dis1989; 13: 31–37.
25.
CloseCFSex, diabetes duration and microalbuminuria in type I diabetes. Diabetologia1987; 30: 508A.
26.
MattockMBKeenHVibertiGCCoronary heart disease and urinary albumin excretion in type 2 diabetic patients. Diabetologia1988; 31: 82–87.
27.
YaqoobMPatrickAWMcClellandPRelationship between markers of endothelial dysfunction, oxidant injury and tubular damage in patients with insulin-dependent diabetes. Clin Sci1993; 85: 557–562.
28.
VibertiGCEtiology and prognostic significance of albuminuria in diabetes. Diabetes Care1988; 11 (10): 840–845.
HostetterTHTroyJCBrennerBMGlomerular haemodynamics in experimental diabetes mellitus. Kidney Int1981; 19: 410–415.
31.
JensenPKChristensenJSStevenKRenal function in streptozotocin-diabetic rats. Diabetologia1981; 21: 409–414.
32.
HostetterTHRennkeHGBrennerBMThe case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 1982; 72: 373–380.
33.
AllawiJJarrettRJMicroalbuminuria and cardiovascular risk factors in type 2 diabetes mellitus. Diabetic Med1990; 7: 115–118.
34.
ParvingHHAndersenARSmidtUMDiabetic nephropathy and arterial hypertension. Diabetologia1983; 24: 10–12.
35.
SampsonMSChambersJSprigingsDIntraventricular septal hypertrophy in type I diabetic patients with microalbuminuria or early proteinuria. Diabetic Med1990; 7: 126–131.
36.
NelsonRGPettittDSCarraherMJThe effect of proteinuria on mortality in non-insulin dependent diabetes. Diabetes1988; 37: 1499–1504.
37.
Kofoed-EnevoldsenAJensenTBorch-JohnsenKIncidence of retinopathy in type I diabetes: association in nephropathy. J Diabetic Complications1987; 3: 96–99.
38.
MathiesenERRonnRJensenTMicroalbuminuria precedes elevation in blood pressure in diabetic nephropathy. Diabetologia1988; 31: 519A.
39.
BrennerBMMeyerTWHostetterTHDietary protein intake and the progressive nature of kidney disease: the role of haemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in ageing, renal ablation and intrinsic renal disease. N Engl J Med1982; 307: 652–659.
40.
HostetterTHOlsonICRennkeHGHyperfiltration in remnant nephrons: a potentially adverse response to ablation. Am J Physiol1981; 241: F85–93.
41.
GuthrowCEMorrisMADayJFEnhanced non-enzymatic glycocylation of human serum albumin in diabetes mellitus. Proc Natl Acad Sci USA1979; 76: 4258–4261.
42.
CohenMPUrodaniviaESurmaMNon-enzymatic glycocylation of basement membranes in in-vitro studies. Diabetes1981; 30: 367–371.
43.
WilliamsSKDevennyJJBitenskyMWMicropinocytic ingestion of glycocylated albumin by isolated microvessels: possible role in pathogenesis of diabetic microangiopathy. Proc Natl Acad Sci USA1981; 78: 2393–2397.
44.
GhiggeriGMCandianaGDelfinoGElectrical charge of serum and urinary albumin in normal and diabetic humans. Kidney Int1985; 28: 168–177.
45.
WilliamsSKSiegelRKPreferential transport of non-enzymatically glycocylated ferritin across the kidney glomerulus. Kidney Int1985; 28: 146–152.
46.
MogensenCEMicroalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med1984; 310: 356–360.
47.
NathamDMLongterm complications of diabetes mellitus. N Engl J Med1993; 328: 1676–1685.
48.
Feldt-RasmussenBHegedusLMathiesenERKidney volume in type I diabetic patients with normal or increased urinary albumin excretion: effect of longterm improved metabolic control. Scand J Clin Lab Invest1991; 51: 31–36.
49.
MauerSMSteffesMWEllisENStructural–functional relationships in diabetic nephropathy. J Clin Invest1984; 74: 1143–1155.
GatlingWKnightEMullerMAMicroalbuminuria in diabetes: a population study of the prevalence and an assessment of three screening tests. Diabetic Med1988; 5: 343–347.
52.
VibertiGCWalkerJDDiabetic nephropathy: etiology and prevention. Diabetes Metab Rev1988; 4: 147–162.
53.
MogensenCEA complete screening of urinary albumin concentration in an unselected diabetic outpatient clinic population. Diab Nephropathy1983; 2: 11–18.
54.
McMillanMADiabetic nephropathy — progress but not cure. Hosp Update1990; 16 (12): 947–948.
55.
JonesSLTrevisenRTariqTSodiumlithium counter-transport in microalbuminuric insulin-dependent diabetics. Hypertension1990; 15: 570–575.
56.
ParvingHHJensenHMogensenCEIncreased urinary albumin excretion rate in benign essential hypertension. Lancet1978; 1: 1190–1192.
57.
BirkenhagerWHSchalekampMAControl Mechanisms in Essential Hypertension. New York–Amsterdam: Elsevier Scientific Publishing Company, 1976; pp. 43–62.
58.
LjungmanSAurellMHartfordMBlood pressure and renal function. Acta Med Scand1980; 208: 17–25.
59.
HallJEGuytonACControl of sodium excretion and arterial pressure by intrarenal mechanisms and the renin-angiotensin system. In: Hypertension: Pathophysiology, Diagnosis, and Management. (LaraghJHBrennerBM eds). New York: Raven Press, 1990; pp. 1105–1129.
60.
DeenWMSatratBDeterminants of the glomerular filtration of proteins. Am J Physiol1981; 241: F162–170.
61.
BohrerMPDeenWMRobertsonCRMechanism of angiotensin II-induced proteinuria in the rat. Am J Physiol1977; 2 (1): F13–21.
62.
EisenbachGMVan LiewJBBoylanJWEffect of angiotensin on the filtration of protein in the rat kidney: a micro-puncture study. Kidney Int1975; 8: 80–87.
63.
HumphreysMHAlfreyACVascular diseases of the kidney. In: The Kidney3rd edn. (BrennerBMRectorFC eds). Philadelphia, WB Saunders Co., 1986, pp. 1175–1220.
64.
MujaisSKEmmanouelDSKasinathBSMarked proteinuria in hypertensive nephrosclerosis. Am J Nephrol1985; 5: 190–195.
65.
MeyerTWAndersonSRennkeHGReversing glomerular hypertension stabilizes established glomerular injury. Kidney int 1987; 31: 752–759.
66.
HarveyTMHowieAJLeeSJRenal biopsy findings in hypertensive patients with proteinuria. Lancet1992; 340: 1435–1436.
67.
OpsalJAAbrahamPAHalstensonCECorrelation of office and ambulatory blood pressure with urinary albumin and N-acetyl-β-Dglucosaminidase excretion in essential hypertension. Am J Hypertens1988; l (suppl 1: 117s–120s.
68.
KaplanNMMicroalbuminuria: a risk factor for vascular and renal complications of hypertension. Am J Med1992; 92 (suppl 4B: 413s–418s.
69.
GoslingPBeeversDGUrinary albumin excretion and blood pressure in the general population. Clin Sei1989; 76: 39–42.
70.
GioconiSLevantiCFommeiEMicroalbuminuria and casual and ambulatory blood pressure in normatensives and patients with borderline and mild essential hypertension. Am J Hypertens1989; 2: 259–261.
71.
Van HooftMSSchalekampADHHofmanARenal haemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with hypertensive and normal parents. N Engl J Med1991; 324: 1305–1311.
72.
GrunfeldBPerelsteinESimóloRRenal functional reserve and microalbuminuria in offspring of hypertensive parents. Hypertension1990; 15: 257–261.
73.
GerberLMShmukerCAldermanMHDifferences in urinary albumin excretion rate between normotensive and hypertensive, white and non-white subjects. Arch Intern Med1992; 152: 373–377.
74.
RitzEFliserDClinical relevance of albumin in hypertensive patients. Clin Invest1992; 70: s114–s119.
75.
SamuelssonOProteinuria as a prognostic factor during longterm hypertensive care. Drugs 1988; 35: 48–54.
76.
McKennaMJAriasCFeldkampCSMicroalbuminuria in clinical practice. Arch Intern Med1991; 151: 1745–1747.
77.
BigazziRBianchiSCampeseVMPrevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. Nephron1992; 61: 94–97.
78.
MessentJWElliottTGHillRDPrognostic significance of microalbuminuria in insulin-dependent diabetes mellitus. Kidney Int1992; 41 (4): 836–839.
79.
JensenTBorch-JohnsenKKofoed-EnevoldsenACoronary heart disease in young type I diabetic patients with and without diabetic nephropathy: Incidence and risk factors. Diabetologia1987; 30: 144–148.
80.
Feldt-RasmussenBMathiesenERDeckertTEffect of two years strict metabolic control on progression of insipient nephropathy in insulin-dependent diabetes. Lancet1986; 1: 1300–1304.
81.
Borch-JohnsenKAndersenPKDeckertTThe effect of proteinuria on relative mortality in type I diabetes mellitus. Diabetologia1985; 28: 590–596.
82.
Borch-JohnsenKKreinerSProteinuria: value as predictor of cardiovascular mortality in insulin-dependent diabetes mellitus. Br Med J1987; 294: 1651–1654.
83.
Borch-JohnsenKThe prognosis of insulin-dependent diabetes mellitus. An epidemiological approach. Dan Med Bull1989; 36: 336–348.
84.
BryanJAnnual checks save kidneys. Healthcare Manage1993; 1 (7): 38.
85.
PanzramGMortality and survival in type 2 diabetes mellitus. Diabetologia1987; 30: 123–131.
86.
MattockMBMorrishNJKeenHProspective study of microalbuminuria as predictor of mortality in non-insulin dependent diabetes. Diabetes1992; 41: 736–741.
87.
FabreJBalantLPDayerPCThe kidney in maturity-onset diabetes mellitus: a clinical study of 510 patients. Kidney Int1982; 21: 730–738.
88.
RettigBTeutschSMThe incidence of end-stage renal disease in Type 1 and 2 diabetes mellitus. Diab Nephrop1984; 3: 26–27.
89.
WinocourPHDharHAndersonDCThe relationship between autonomic neuropathy and urinary sodium and albumin excretion in insulin-treated diabetics. Diabetic Med1986; 3: 436–440.
90.
CatlingWRole of microalbuminuria in diabetes care. Hosp Update1993; 19 (2): 105–110.
91.
KeenHMicroalbuminuria: marker of risk of diabetic complications. Care of the Elderly1993; 5 (11): 398–402.
92.
EwingDSCampellIWClarkBFThe natural history of diabetic neuropathy. Quart J Med1980; 49: 95–108.
93.
ScmitzAVaethMMicroalbuminuria: a major risk factor in non-insulin dependent diabetes. A 10-year follow-up of 503 patients. Diabetic Med1988; 5: 126–134.
94.
Valdorf-HansenFJensenTBorch-JohnsenKCardiovascular risk factors in type I diabetic patients with and without proteinuria. Acta Med Scand1987; 222: 439–444.
95.
TelmerSSandahlCJAndersenARSmoking habits and prevalence of clinical diabetic micro-aniopathy in insulin-dependent diabetics. Acta Med Scand1984; 215: 63–65.
96.
JensenTSteinerSDeckertTAbnormalities in plasma concentration of lipoproteins and fibrinogen in type I diabetic patients with increased urinary albumin excretion. Diabetologia1988; 31: 142–145.
97.
DamsgaardEMFrolandAJorgensenDDEight to nine year mortality in known non-insulin dependent diabetes and controls. Kidney Int1992; 41 (4): 731–735.
98.
CerasolaGCottoneSD'IgnotoGMicroalbuminuria as a predictor of cardiovascular damage in essential hypertension. J Hypertens1989; 7 (suppl 6): s352–s353.
99.
YudkinJSForrestRDJacksonCAMicroalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet1988; 1: 530–533.
100.
SchiemerREMesserliFHGaravagliaGEHigh intraglomerular pressure: a determinant of early target-organ damage in arterial hypertension. J Hypertens1986; 4 (suppl 5): s261–263.
101.
WinocourPHBhatwagarDIsholaMLipoprotein and microvascular disease in type I Diabetes Mellitus. Diabetic Med1991; 8: 922–927.
102.
WinocourPHDurringtonPNIsholaMInfluence of proteinuria on vascular disease, blood pressure, and lipoproteins in insulin-dependent diabetes mellitus. Br Med J1987; 294: 1648–1651.
103.
NelsonRGPettittDJCammerMJThe effects of proteinuria on mortality in non-insulin dependent diabetes mellitus. Diabetes1988; 37: 1499–1504.
104.
BulpittCJBelihnLJCliftonPRisk factors for death in treated hypertensive patients. Reports from DHSS hypertension care computing project. Lancet1979; 11: 134–137.
105.
WinocourPHHarlandJOEMillarJPMicroalbuminuria and associated cardiovascular risk factors in the community. Atherosclerosis1992; 93: 71–81.
106.
HaffnerSMSternMPGruberKKMicroalbuminuria: potential marker for increased cardiovascular risk factors in non-diabetic subjects. Arteriosclerosis1990; 10: 127–131.
107.
ParvingHHJensenHAEWestrupMIncreased transcapillary escape rate of albumin and IgG in essential hypertension. Scand J Clin Lab Invest1977; 37: 223–227.
108.
DamsgaardEMFrolandAJorgensenODMicroalbuminuria as predictor of increased mortality in elderly people. Br Med J1990; 300: 297–300.
109.
DamsgaardEMMogensenCEMicroalbuminuria in elderly hyperglycaemic patients and controls. Diabetic Med1986; 3: 430–433.
110.
KeenHChlouverakisCFullerJThe concominants of raised blood sugar: studies on newly-detected hyperglycaemics. II Urinary albumin excretion, blood pressure and their relation to blood sugar levels. Guy's Hospital Reports1969; 118: 247–254.
111.
StehouwerCDNautaJJZeldenrustGCUrinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin dependent diabetes. Lancet1992; 340: 319–323.
112.
JensenJAFrancisCWWagnerDDFibrin-induced release of Von-Willenbrand factor from endothelial cells. J Clin Invest1987; 79: 117–123.
113.
TroopMJDallingerKJLJenningsPEAngiotensin converting enzyme: relationship to insulin-dependent diabetes and microangiopathy. Diabetic Med1986; 3: 455–457.
114.
JensenTBjerre-KnudsenJFeldt-RasmussenBFeatures of endothelial dysfunction in early diabetic nephropathy. Lancet1989; 1: 461–463.
115.
ParvingHHGyntelbergFTranscapillary escape rate of albumin and plasma volume in essential hypertension. Circ Res1973; 32: 643–651.
116.
PedersenEBMogensenCEEffects of antihypertensive treatment on urinary albumin excretion, glomerular filtration rate, and renal plasma now in patients with essential hypertension. Scand J Clin Lab Invest1976; 36: 231–237.
117.
RossRThe pathogenesis of atherosclerosis: an update. N Engl J Med1986; 314: 488–500.
118.
VaneJRAnggardEEBottingRMMechanisms of disease: regulatory functions of the vascular endothelium. N Engl J Med1990; 323: 27–36.
119.
JonesCLCloseCFMattockMBPlasma lipid and coagulation factor concentrations in insulin-dependent diabetics with microalbuminuria. Br Med J1989; 298: 487–490.
120.
WinocourPHDurringtonPNBhatnagarDThe influence of early diabetic nephropathy on very low density lipoprotein, intermediate density lipoprotein, and low density lipoprotein composition. Atherosclerosis1991; 89: 49–57.
121.
WinocourPHBhatnagarDIsholaMLipoprotein (a) and microvascular disease in type I diabetes mellitus. Diabetic Med1991; 8: 922–927.
122.
ReavenGMThe role of insulin resistance in human disease. Diabetes1988; 37: 1595–1607.
123.
O'DonnellMJLe GuenCALawsonNPlatelet behaviour in type I diabetic patients with and without albuminuria. Diabetic Med1991; 8: 624–628.
124.
GoslingPSutcliffeAJProteinuria following trauma. Ann Clin Biochem1986; 23: 681–685.
125.
GoslingPSutcliffeAJCooperMABurn and trauma associated proteinuria: the role of lipid peroxidation, renin and myoglobin. Ann Clin Biochem1988; 25: 53–59.
126.
GoslingPShearmanCPGwynnBRMicroalbuminuria: response to operation. Br Med J1988; 296: 338–339.
127.
ShearmanCPGoslingPMicroalbuminuria and vascular permeability. Lancet1988; ii: 906–907.
128.
GoslingPHughesEAReynoldsTMMicroalbuminuria is an early response following acute myocardial infarction. Eur Heart J1991; 12 (4): 508–513.
129.
KaplanBSKlassenJGaultMHGlomerular injury in patients with neoplasia. Ann Rev Med1976; 27: 117–125.
130.
EagenJWLewisEJGlomerulopathies of neoplasia. Kidney Int1977; 11: 297–306.
131.
HemmingsenLSkaarupPUrinary excretion of ten plasma proteins and peptides in the urine of patients with extrarenal epithelial carcinoma. Acta Chir Scand1977; 143: 177–183.
132.
SawyerNWedsworthJWijrenMPrevalence, concentration, and prognostic importance of proteinuria in patients with malignancies. Br Med J1988; 296: 1295–1298.
133.
FleckARainesGHawkerFIncreased vascular permeability: a major cause of hypoalbuminaemia in disease and injury. Lancet1985; 1: 781–784.
134.
GoslingPAndrewsDJChesnerIMEffect of antiinflammatory drugs on urinary microaibuminurin excretion. Lancet1991; 337: 855.
135.
WilkinsonRMilledgeJSLandaMJMicroalbuminuria in chronic obstructive lung disease. Br Med J1993; 307: 239.
136.
ChaudharyBASklarAHChaudharyTKSleep apnoea, proteinuria, and nephrotic syndrome. Sleep1988; 11 (1): 69–74.
137.
MadedduPEnaPGloriosoNHigh prevalence of microproteinuria, an early index of renal impairment in patients with diffuse psoriasis. Nephron1988; 48 (3): 222–225.
138.
MitchellSCMSheldonTAShawABQuantification of proteinuria: a reevaluation of the protein/creatinine ratio for elderly subjects. Age Ageing1993; 22: 443–449.
139.
ParvingHHNoerIDeckertTThe effect of metabolic regulation on microvascular permeability to small and large molecules in short-term juvenile diabetes. Diabetologia1976; 12: 161–166.
140.
VibertiGCMacKintoshDBilousRWProteinuria in diabetes mellitus: role of spontaneous and experimental variation of glycaemia. Kidney Int1982; 21: 714–720.
141.
WattsGFPillayDEffect of ketones and glucose on the estimation of urinary creatinine: implications for microalbuminuria screening. Diabetic Med1990; 7: 263–265.
142.
ChapmanS Screening for microalbuminuria. Care of the Elderly (suppl): Ace inhibitors and vascular disease, 1994; 13–15.
143.
MogensenCEMicroalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int1987; 31: 673–689.
144.
SpoorenPFLekkerkerkerJFVermesIMicral-test: a qualitative dipstick test for microalbuminuria. Diabetes Res Clin Pract1992; 18: 83–87.
145.
AgardhCDA new semiqualitative rapid test for screening for microalbuminuria. Practical Diabetes1993; 10 (4): 146–147.
146.
AdamsonCLKumarSSutcliffeHScreening strategies in the detection of microalbuminuria in insulin-dependent diabetic patients. Practical Diabetes1994; 10 (4): 142–144.
147.
RaschRPrevention of diabetic glomerulopathy in streptozotocyn diabetic rats by insulin treatment. Diabetologia1979; 16: 319–324.
148.
RaschRPrevention of diabetic glomerulopathy in streptozotocyn diabetic rats by insulin treatment: albumin excretion. Diabetologia1980; 18: 413–416.
The Diabetic Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med1993; 329 (14): 977–986.
151.
Kroc Collaborative Study Group; Diabetic retinopathy after two years of intensified insulin treatment. JAMA1988; 260: 37–41.
152.
Feldt-RasmussenBMathiesenERJensenTEffect of improved metabolic control on loss of kidney function in insulin-dependent diabetic patients: an update of the Steno study. Diabetologia1991; 34: 164–170.
153.
BrinchmannHDahl-JorgensenKSadvickLBlood glucose concentrations and progression of diabetic retinopathy: the seven year results of the Oslo study. Brit Med J1992; 304: 19–22.
154.
ReichardPNillsonBYRosenquvistMDThe effect of longterm intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med1993; 329: 304–309.
155.
WanPHLauJChalmorcTCMetaanalysis of effects of intensive blood glucose control on late complications of type I diabetes. Lancet1993; 341: 306–309.
156.
VibertiGCRickupJCJarrettRJEffect of control of blood glucose on urinary excretion of albumin and β2-microglobulin in insulin-dependent diabetes. N Engl J Med1979; 300: 638–641.
157.
MauerSMBrownMMatasAJEffects of pancreatic islet transplantation on the increased urinary albumin excretion rates in intact and uninephrectomised rats with diabetes mellitus. Diabetes1978; 27: 959–964.
158.
ChristiansenJSGammelgaardJTronierBKidney function and size in diabetics before and during initial treatment. Kidney Int1982; 21: 683–688.
159.
Kroc Collaborative Study Group: Blood glucose control and the evolution of diabetic retinopathy and albuminuria. N Engl J Med1984; 311: 365–372.
160.
WisemanMJSaundersAJKeenHEffect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes. N Engl J Med1985; 312: 617–621.
161.
ReichardPRosenqvistUNephropathy is delayed by intensified insulin treatment in patients with insulin-dependent diabetes mellitus and retinopathy. J Intern Med1989; 226: 81–87.
162.
TamborlaneWVPuklinJEBergmanMLongterm improvement of metabolic control with the insulin pump does not reverse diabetic microangiopathy. Diabetes Care1982; 5 (suppl 1): 58–64.
163.
VibertiGCMacKintoshDBendingJJLongterm correction of hyperglycaemia and progression of renal failure in insulin-dependent diabetes. Br Med J1983; 286: 598–602.
164.
AmielSADiabetic control and complications. Br J Med1993; 307: 881–882.
165.
U.K. Prospective Diabetic Study Group. UKPDS VIII. Study design, progress, and performance. Diabetologia1991; 34: 877–890.
166.
ChristensenCKMogensenCEAntihypertensive treatment: longterm reversal of progression of albuminuria in incipient diabetic nephropathy. A longitudinal study of renal function. J Diabetic Complications1987; 1: 45–52.
167.
Melbourne Diabetic Nephropathy Study Group. Comparison between perindropil and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Br Med J1991; 302: 210–216.
168.
MarreMChatellierGLeblancHConverting enzyme inhibition and kidney function in normotensive diabetic subjects with persistent microalbuminuria. Brit Med J1987; 294: 1448.
169.
MathiesenERHommelEGieseJEfficacy of Captopril in postponing nephropathy in normotensive, insulin-dependent diabetic patients with microalbuminuria. Brit Med J1991; 303: 81–87.
170.
HommelCParvingHHMathiesenEEffect of Captopril on kidney function in insulin-dependent diabetic patients with nephropathy. Brit Med J1986; 293: 467–470.
171.
TagumaYKilamotoYFutakiGEffect of Captopril on heavy proteinuria in azotemic diabetics. N Engl J Med1985; 313: 1617–1620.
172.
BjorkSMulecHJohnsenSARenal protective effect of enalapril in diabetic nephropathy. Brit Med J1992; 304: 339–343.
173.
LewisEJHunsickerLGBainRPThe effects of ACE inhibition on diabetic nephropathy. N Engl J Med1993; 329: 1456–1462.
174.
ParvingHHHommelEPrognosis in diabetic nephropathy. Brit Med J1989; 299: 230–233.
175.
MathiesenERBorch-JohnsenKJensenDVImproved survival in patients with diabetic nephropathy. Diabetologia1989; 32: 884–886.
176.
WalkerJDImplications of microalbuminuria in diabetes. Br J Hosp Med1991; 45: 41–44.
177.
EpsteinMCalcium antagonists and diabetic nephropathy. Arch Intern Med1991; 151: 2361–2364.
178.
MogensenCEACE inhibitors and diabetic nephropathy. Br Med J1992; 304: 327–328.
179.
KasiskeBLKalilRSNLiasMEffect of antihypertensive therapy on the kidney of patients with diabetes: a meta-analysis. Ann Intern Med1993; 118: 129–138.
180.
PedersenMMSchmitzAPedersenEBAcute and longterm renal effects of ACE inhibition in normotensive, normoalbuminuric insulin-dependent diabetic patients. Diabetic Med1988; 5: 562–569.
181.
MorelliELoonNMeyerTEffects of ACE inhibition on barrier function in diabetic glomerulopathy. Diabetes1990; 39: 76–82.
182.
IchikawaIIkomaMFogoAGlomerular growth promoters, the common key mediator for progressive glomerular sclerosis in chronic renal disease. Adv Nephrol1991; 20: 127–148.
183.
VibertiGCMogensenCEGroopLCEuropean Microalbuminuria Captopril Study Group: Effect of Captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. JAMA1994; 271 (4): 275–279.
184.
WiegmannTBHerronKGChonkoAMEffect of ACE inhibition on renal function and albuminuria in normotensive type I diabetic patients. Diabetes1992; 41: 62–67.
185.
CohenDDoddsRVibertiGCEffect of protein restriction in insulin-dependent diabetics at risk of nephropathy. Brit Med J1987; 294: 795–798.
186.
CiavarellaADiMizioGStefoniSReduced albuminuria after dietary protein restriction in insulin-dependent diabetic patients with clinical nephropathy. Diabetic Care1987; 10: 407–413.
187.
ZellerKWhittakerEJuliivanLEffect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. N Engl J Med1991; 324: 78–84.
188.
BianchiSBigazziRBaldariGMicroalbuminuria in patients with essential hypertension: effect of ACE inhibitor and of a calcium channel blocker. Am J Hypertens1991; 4: 291–296.
189.
BianchiSBigazziRBaldariGMicroalbuminuria in patients with essential hypertension: effects of several antihypertensive drugs. Am J Med1992; 93: 525–528.
190.
HartfordMWendelhagIBerglundGCardiovascular and renal effects of longterm antihypertensive treatment. JAMA1988; 259 (17): 2553–2557.
191.
HeegEDe JongPEVander HemGKEfficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. Kidney Int1989; 36: 272–279.
192.
CollinsRPetoRMacMahonSBlood pressure, stroke, and coronary heart disease. Lancet1990; 335: 827–838.
193.
KvensHMJPortaMKeenHDiabetes care and research in Europe: the St. Vincent declaration action programme. Implementation document. G Ital Diabetologia1992; 12 (suppl 2): 1–56.
194.
The 1992 WHO Study Group on Prevention of Diabetes. WHO Tech. Report No. 12 (in preparation).
195.
SiegelJEKrolewskiASWarramJHCost-effectiveness of screening and early treatment of nephropathy in patients with insulin-dependent diabetes mellitus, J Am Soc Nephrol1992; 3: 3111–3119.
196.
Borch-JohnsenKWenzelHVibertiGCIs screening and intervention for microalbuminuria worthwhile in patients with insulin-dependent diabetes?Br Med J1993; 306: 1722–1725.
197.
ChapmanSRUsing PACT data to evaluate the cost of community pharmacy screening for microalbuminuria in diabetics. Pharmaceutical J1992; 249 (Pharm Pract Res suppl: R7.
198.
RitzEFliserDClinical relevance of albuminuria in hypertensive patients. Clin Invest1992; 70: s114–119.
